Proleukin [aldesleukin] in combination with Rituxan [rituximab] in patients with low-grade non-Hodgkin's lymphoma who have previously failed Rituxan treatments

Trial Profile

Proleukin [aldesleukin] in combination with Rituxan [rituximab] in patients with low-grade non-Hodgkin's lymphoma who have previously failed Rituxan treatments

Completed
Phase of Trial: Phase II/III

Latest Information Update: 03 Feb 2006

At a glance

  • Drugs Aldesleukin; Rituximab
  • Indications Non-Hodgkin's lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top